| Application no. and date | 22170364.8 (espacenet) (Federated) (European Patent Register), 20130605 | | Patent/reg. no. and date | DK/EP 4104824, 20250521 | | Publication date | 20221221 | | Priority no. and date | US 201261656451 P, 20120606 | | EP pub. no. and date |
EP 4104824 20221221 | | Effective date | | | Applicant/owner | Nalpropion Pharmaceuticals LLC, 155 Franklin Rd, Suite 450
Brentwood, TN 37027, US | | Applicant ref. no. | V494205DK00 | | Inventor | KLASSEN, Preston,
La Jolla, 92037, US,
TAYLOR, Kristin,
San Diego, 92127, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/485 (2006.01) , A61K 9/20 (2006.01) , A61P 3/04 (2006.01) , A61P 9/00 (2006.01) , A61P 9/04 (2006.01) , A61P 9/10 (2006.01) , G01G 19/414 (2006.01) , G09B 19/00 (2006.01) , G09B 5/06 (2006.01) , G16H 20/10 (2018.01) | | Title | SAMMENSÆTNING TIL BRUG I EN FREMGANGSMÅDE TIL BEHANDLING AF OVERVÆGT OG FEDME HOS PATIENTER MED HØJ KARDIOVASKULÆR RISIKO | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
